Padilla RÁL, Alban LF, Gerson R

Idioma: Español
Referencias bibliográficas: 15
Paginas: 154-160
Archivo PDF: 213.96 Kb.

RESUMEN

Los tumores neuroendocrinos de pulmón son un grupo poco frecuente de neoplasias pulmonares que difieren en su origen, características clínicas, histológicas y en su tratamiento, de las formas no endocrinas de tumores pulmonares. Comprenden cuatro entidades con curso biológico diferente: tumor carcinoide, tumor carcinoide atípico, carcinoma neuroendocrino de células pequeñas y carcinoma neuroendocrino de células grandes. Presentamos un caso de una mujer de 52 años con carcinoma neuroendocrino de células pequeñas de pulmón en etapa avanzada. Se discuten las características generales e histogénesis de los tumores neuroendocrinos de pulmón; así como las estrategias de tratamiento en el carcinoma de células pequeñas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Beasley MB, Brambilia E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005; 40: 90-97.

2. Ito T, Nogawa H, Udaka N et al. Development of pulmonary neuroendocrine cells of fetal hamster in explant culture. Lab Invest 1997; 77: 449-457.

3. Gosney JR. Neuroendocrine cell populations in postnatal human lungs: Minimal variation from childhood to old age. Anat Rec 1993; 236: 177-180.

4. Gosney JR, Sissons MC, Allibone RO. Neuroendocrine cell populations in normal human lungs: A quantitative study. Thorax 1988; 43: 878-882.

5. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer 2008; 113: 5-21.

6. Adriaensen D, Brouns I, Pintelon I et al. Evidence for a role of neuroepithelial bodies as complex airway sensors: Comparison with smooth muscle-associated airway receptors. J Apll Physiol 2006; 101: 960-970.

7. Van Lommel A. Pulmonary neuroendocrine cells (PNEC) and neuroepithelial bodies (NEB): Chemoreceptors and regulators of lung development. Paediatr Respir Rev 2001; 2: 171-176.

8. Travis WD. The concept of pulmonary neuroendocrine tumours. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004.

9. Fink G, Krelbaum T, Yellin A et al. Pulmonary carcinoid: Presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119: 1647-1651.

10. Zacharias J, Nicholson AG, Ladas GP et al. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: Prognosis alter complete resection and systematic nodal dissection. Ann Thorac Surg 203; 75: 348-352.

11. Nicholson SA, Beasley MB, Brambilia E et al. Small cell lung carcinoma (SCLC): A clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002; 26: 1184-1197.

12. Abidin AZ, Garassino MC et al. Targeted therapies in small cell lung cancer. Therapeutic Advances in Medical Oncology 2010; 2: 25-37.

13. Small Cell Lung Cancer Treatment (PDQ). National Cancer Institute: www.cancer.gov 2009.

14. Spira A, Ettinger D. Multidisciplinary Management of Lung Cancer. New Engl J Med 2004; 350: 379-392.

15. Elias A, Baldini E. Last Literature Review 17.3 Small Cell Lung Cancer Treatment. UpToDate 2009.